542 related articles for article (PubMed ID: 1634608)
1. A T cell-dependent experimental liver injury in mice inducible by concanavalin A.
Tiegs G; Hentschel J; Wendel A
J Clin Invest; 1992 Jul; 90(1):196-203. PubMed ID: 1634608
[TBL] [Abstract][Full Text] [Related]
2. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.
Toyabe S; Seki S; Iiai T; Takeda K; Shirai K; Watanabe H; Hiraide H; Uchiyama M; Abo T
J Immunol; 1997 Aug; 159(3):1537-42. PubMed ID: 9233653
[TBL] [Abstract][Full Text] [Related]
3. Metformin aggravates immune-mediated liver injury in mice.
Volarevic V; Misirkic M; Vucicevic L; Paunovic V; Simovic Markovic B; Stojanovic M; Milovanovic M; Jakovljevic V; Micic D; Arsenijevic N; Trajkovic V; Lukic ML
Arch Toxicol; 2015 Mar; 89(3):437-50. PubMed ID: 24770553
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice.
Santucci L; Fiorucci S; Cammilleri F; Servillo G; Federici B; Morelli A
Hepatology; 2000 Feb; 31(2):399-406. PubMed ID: 10655263
[TBL] [Abstract][Full Text] [Related]
5. Concanavalin A hepatotoxicity in mice: tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation.
Künstle G; Hentze H; Germann PG; Tiegs G; Meergans T; Wendel A
Hepatology; 1999 Nov; 30(5):1241-51. PubMed ID: 10534346
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis.
Lee WY; Salmi M; Kelly MM; Jalkanen S; Kubes P
Hepatology; 2013 Oct; 58(4):1413-23. PubMed ID: 23686782
[TBL] [Abstract][Full Text] [Related]
7. Fumigaclavine C improves concanavalin A-induced liver injury in mice mainly via inhibiting TNF-alpha production and lymphocyte adhesion to extracellular matrices.
Zhao Y; Liu J; Wang J; Wang L; Yin H; Tan R; Xu Q
J Pharm Pharmacol; 2004 Jun; 56(6):775-82. PubMed ID: 15231043
[TBL] [Abstract][Full Text] [Related]
8. Experimental hepatitis and role of cytokines.
Tiegs G
Acta Gastroenterol Belg; 1997; 60(2):176-9. PubMed ID: 9260332
[TBL] [Abstract][Full Text] [Related]
9. Protectin D1 reduces concanavalin A-induced liver injury by inhibiting NF-κB-mediated CX3CL1/CX3CR1 axis and NLR family, pyrin domain containing 3 inflammasome activation.
Ren J; Meng S; Yan B; Yu J; Liu J
Mol Med Rep; 2016 Apr; 13(4):3627-38. PubMed ID: 26955849
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-11 reduces T-cell-dependent experimental liver injury in mice.
Bozza M; Bliss JL; Maylor R; Erickson J; Donnelly L; Bouchard P; Dorner AJ; Trepicchio WL
Hepatology; 1999 Dec; 30(6):1441-7. PubMed ID: 10573523
[TBL] [Abstract][Full Text] [Related]
11. A novel accessory role of neutrophils in concanavalin A-induced hepatitis.
Hatada S; Ohta T; Shiratsuchi Y; Hatano M; Kobayashi Y
Cell Immunol; 2005 Jan; 233(1):23-9. PubMed ID: 15893298
[TBL] [Abstract][Full Text] [Related]
12. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines.
Fiorucci S; Santucci L; Antonelli E; Distrutti E; Del Sero G; Morelli O; Romani L; Federici B; Del Soldato P; Morelli A
Gastroenterology; 2000 Feb; 118(2):404-21. PubMed ID: 10648469
[TBL] [Abstract][Full Text] [Related]
13. Effects of intravenous immunoglobulins on T-cell mediated, concanavalin A-induced hepatitis in mice.
Shirin H; Bruck R; Aeed H; Hershkoviz R; Lider O; Kenet G; Avni Y; Halpern Z
Liver; 1997 Dec; 17(6):275-80. PubMed ID: 9455732
[TBL] [Abstract][Full Text] [Related]
14. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor.
Gantner F; Leist M; Lohse AW; Germann PG; Tiegs G
Hepatology; 1995 Jan; 21(1):190-8. PubMed ID: 7806154
[TBL] [Abstract][Full Text] [Related]
15. Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice.
Knolle PA; Gerken G; Loser E; Dienes HP; Gantner F; Tiegs G; Meyer zum Buschenfelde KH; Lohse AW
Hepatology; 1996 Oct; 24(4):824-9. PubMed ID: 8855184
[TBL] [Abstract][Full Text] [Related]
16. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.
Mizuhara H; O'Neill E; Seki N; Ogawa T; Kusunoki C; Otsuka K; Satoh S; Niwa M; Senoh H; Fujiwara H
J Exp Med; 1994 May; 179(5):1529-37. PubMed ID: 8163936
[TBL] [Abstract][Full Text] [Related]
17. Midzonal necrosis of the liver after concanavalin A-injection.
Satoh M; Kobayashi K; Ishii M; Igarashi T; Toyota T
Tohoku J Exp Med; 1996 Oct; 180(2):139-52. PubMed ID: 9111763
[TBL] [Abstract][Full Text] [Related]
18. Effect of diphenyl dimethyl bicarboxylate on concanavalin A-induced liver injury in mice.
Gao M; Zhang J; Liu G
Liver Int; 2005 Aug; 25(4):904-12. PubMed ID: 15998443
[TBL] [Abstract][Full Text] [Related]
19. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C
J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498
[TBL] [Abstract][Full Text] [Related]
20. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A.
Küsters S; Gantner F; Künstle G; Tiegs G
Gastroenterology; 1996 Aug; 111(2):462-71. PubMed ID: 8690213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
